Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

MelaFind PMA Approval Sets Stage For Early 2012 Debut

07 Nov 2011

Related Content

Mela Sciences Cites Binding Study Protocol Pact As Key To FDA Reversal On <i>MelaFind</i> PMA

03 Oct 2011

Citizen Petition: FDA Reneged On Binding Agreement For Melanoma Device

16 May 2011

Additional Topics

More from Archive

More from Medtech Insight

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.